Presentation TCT 2012

Atorvastatin, Administered at the Onset of Reperfusion, Protects Human Myocardium Against Lethal Reperfusion Injury by Activation of the RISK pathway

Presenter: Paul S. Rees

January 03, 2012

REGISTER for free or LOG IN to view this content

Atorvastatin, Administered at the Onset of Reperfusion, Protects Human Myocardium Against Lethal Reperfusion Injury by Activation of the RISK pathway

CAD Pharma

Lipids

Presentation

TCT 2012

Up Next

Presentation TCT 2012

Drug Eluting Stents in the Treatment of Isolated Proximal LAD Disease are Associated with Similar Outcomes Compared to Minimally Invasive LIMA Grafts

Presenter: Daniel A. Jones

January 03, 2012

More slides +

Presentation TCT 2012

Statin Therapy Reduces Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation

Presenter: Masahiro Natsuaki

January 03, 2012

Presentation TCT 2012

The Impact of Endothelial Wall Shear Stress on Vulnerable Plaque Growth

Presenter: Wang-Soo Lee

January 03, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.